End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer

BACKGROUND: In men undergoing definitive radiation for prostate cancer, it is unclear whether early biochemical response can provide additional prognostic value beyond pre-treatment risk stratification. METHODS: Prostate cancer patients consecutively treated with definitive radiation at our institut...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Prostate Cancer Prostatic Dis
Asıl Yazarlar: Narang, Amol K., Trieu, Janson, Radwan, Noura, Ram, Ashwin, Robertson, Scott P., He, Pei, Gergis, Carol, Griffith, Emily, Singh, Harleen, DeWeese, Tate A., Honig, Stephanie, Annadanam, Anvesh, Greco, Stephen, DeVille, Curtiland, McNutt, Todd, DeWeese, Theodore L., Song, Daniel Y., Tran, Phuoc T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5429233/
https://ncbi.nlm.nih.gov/pubmed/28094250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.67
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller